Can Kailera become the next major GLP-1 challenger after pricing one of biotech’s biggest IPOs in years?
UCB SA (EBR: UCB) bets $1.15 bn on Neurona Therapeutics to push epilepsy treatment beyond symptom control
Read More General news updates Jagdeep Dhankhar affirms India’s judicial sovereignty amid international comments Vice President Jagdeep Dhankhar recently emphasized India’s unique position as a robust democracy, stating that the nation does… byPallavi MadhirajuMarch 30, 2024